Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL8724650

CC(C)C(=O)Oc1ccc(CCNC(=O)c2ccc[n+](C)c2)cc1OC(=O)C(C)C.O=C([O-])C(F)(F)F

nearest known ligand 0.50

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 1/20 0.50
ADRA2A P08913 1/20 0.50
DRD2 P14416 1/20 0.50
ADRA2C P18825 1/20 0.50
DRD1 P21728 1/20 0.50
ADRA1A P35348 1/20 0.50
DRD3 P35462 1/20 0.50
ALOX15 P16050 1/20 0.41
CA1 P00915 1/20 0.40
CA2 P00918 1/20 0.40
CA7 P43166 1/20 0.40
CA9 Q16790 1/20 0.40
CA14 Q9ULX7 1/20 0.40
MAPK1 P28482 1/20 0.40
F10 P00742 2/20 0.39
GAA P10253 2/20 0.38
ALDH1A1 P00352 3/20 0.38
HPGD P15428 1/20 0.38
ALOX12 P18054 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL9011417 0.88 CA1 (0.41) CA1CA2CA7CA9CA14
Iodide SCHEMBL9011351 0.81 TRPV1 (0.50) CA1CA2CA7CA9CA14
Iodide SCHEMBL9011297 0.80 MAPK1 (0.44) CA1CA2CA7CA9CA14
Iodide SCHEMBL9011306 0.73 CA1 (0.52) CA1CA2CA7CA9CA14
Trifluoroacetic Acid SCHEMBL4125186 0.72 ADRB2 (0.62) ADRB2ADRA2ADRD2ADRA2CDRD1
Trifluoroacetic Acid SCHEMBL8724806 0.72 F10 (0.40) CA2F10GAA
SCHEMBL9011198 0.72 MEN1 (0.57) ALOX15CA1CA2CA7CA9
Iodide SCHEMBL8722463 0.71 MEN1 (0.56) ALOX15CA1CA2CA7CA9
SCHEMBL11038683 0.70 RAB9A (0.58) ALDH1A1SMN1; SMN2MAPT
Hydrochloric Acid SCHEMBL4118342 0.69 ADRB2 (0.71) ADRB2ADRA2ADRD2ADRA2CDRD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0335545-B2 Pharmaceutical formulations for parenteral use UNIV FLORIDA (US) 1998-09-23 EP disclosed
EP-0327766-B1 Redox systems for brain-targeted drug delivery UNIV FLORIDA (US) 1998-04-08 EP disclosed
US-5525727-A ANALGESIC OR NARCOTIC ANTAGONIST UNIVERSITY OF FLORIDA (US) 1996-06-11 US disclosed
US-5187158-A Sustained delivery of viricides UNIVERSITY OF FLORIDA (US) 1993-02-16 US disclosed
US-5024998-A Administering in aqueous solution with cyclodextrin derivative UNIVERSITY OF FLORIDA (US) 1991-06-18 US disclosed
US-5017566-A Redox systems for brain-targeted drug delivery UNIVERSITY OF FLORIDA (US) 1991-05-21 US disclosed
US-5008257-A Penicillin or cephalosporin antibiotics UNIVERSITY OF FLORIDA (US) 1991-04-16 US disclosed
US-5002935-A Inclusion Complexing Hydroxypropylcyclodextrin with a Dihydropyridine-substituted Drug UNIVERSITY OF FLORIDA (US) 1991-03-26 US disclosed
US-4983586-A Decreasing precipitation at injection site or in lungs or other organs by combining with hydroxypropyl-beta-cyclodextrin UNIVERSITY OF FLORIDA (US) 1991-01-08 US disclosed
US-4900837-A Brain-specific drug delivery of steroid sex hormones cleaved from pyridinium carboxylates and dihydro-pyridine carboxylate precursors UNIVERSITY OF FLORIDA (US) 1990-02-13 US disclosed
US-4880816-A Brain-specific delivery of dopamine utilizing dihydropyridine/pyridinium salt-type redox carriers UNIVERSITY OF FLORIDA (US) 1989-11-14 US disclosed
US-4880921-A Brain-specific drug delivery UNIVERSITY OF FLORIDA (US) 1989-11-14 US disclosed
EP-0335545-A2 Pharmaceutical formulations for parenteral use UNIVERSITY OF FLORIDA (US) 1989-10-04 EP disclosed
US-4824850-A DIHYDROPYRIDINE-PYRIDINIUM SALT REDOX CARRIER UNIVERSITY OF FLORIDA (US) 1989-04-25 US disclosed
US-4727079-A Brain-specific dopaminergic activity involving dihydropyridine carboxamides, dihydroquinoline and isoquinoline carboxamides UNIVERSITY OF FLORIDA (US) 1988-02-23 US disclosed